Volume 26, Issue 126, August 2022

Outcomes of COVID-19 in sickle cell disease patients

Mahmoud Sulub Alsomali¹, Osama M Binbakheet^2♦, Mohammad Salem Alshammari³, Raffan Abdullah Alghamdi⁴, Sara Adel Aljumaan⁴, Abdul Aziz Abdullah Al Tamimi⁴, Lyana Nabeel Abdrabalnabi⁴, Almaha Bassam Albalwi⁴, Eliya Hussain Almubarak⁴, Mannar Mohammad Saud Al Masaud⁵

¹Emergency Consultant, Program Director of Emergency Medicine, Emergency Department, General Hospital, King Saud Medical City, Riyadh, Saudi Arabia
²Emergency Resident at King Saud Medical City, Riyadh, Saudi Arabia
³Emergency Resident at King Saud Medical City, Riyadh, Saudi Arabia
⁴Medical Intern at Al Maarefa University, Riyadh, Saudi Arabia
⁵Medical intern at Dar Al Uloom University, Riyadh, Saudi Arabia

^♦Corresponding author
Emergency Resident at King Saud Medical City, Riyadh, Saudi Arabia

ABSTRACT

Coronavirus disease 2019 (COVID-19), is an acute respiratory disease that spread widely around the world, causing increased morbidity and mortality. This was a retrospective observational analytical study from April 2020 to August 2021 in admitted COVID19 patients with Sickle Cell Anaemia, in King Saud Medical City. The study aims to evaluate the outcomes of COVID-19 in Sickle Cell Anaemia patients. Analyse the different prognostic factors to identify prognostic factors associated with mortality. The present study is composed of 13 SCD patients (53.8% male’s vs 46.2% females) with a mean age of 29 years old. 6 patients (46.2%) had blood transfusions and 2 patients had bilateral infiltration after a chest x-ray. Patients who required intubation were 15.4% (n=2). 69.2% of the patients were being admitted and the median days of the hospital were 6 days. Finally, the primary limitation of this observational study is the few numbers of SCD who had COVID-19, which raises the possibility of type II statistical error due to the lack of power.

Keywords: Sickle cell, COVID19, Outcomes

Medical Science, 2022, 26, ms341e2416

PDF

DOI: https://doi.org/10.54905/disssi/v26i126/ms341e2416

Published: 18 August 2022